Santhera Finds ‘Elegant Solution’ For Its Finances With Catalyst DMD Drug Deal

US Rights To Vamorolone Licensed For $90m Upfront

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.